Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitor

Masaya Imoto, Naomi Shimura, Ui Hideaki, Kazuo Umezawa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Erbstatin, a tyrosine kinase inhibitor, inhibited epidermal growth factor (EGF)-induced inositol phosphate production in cultured A431 cells. However, it did not inhibit ATP-induced inositol phosphate production. Cytosolic but not membrane-associated phospholipase C was iactivated by EGF, and erbstatin inhibited enhancement of the phospholipiase C activity in EGF-treated cells. Thus, tyrosine kinase of A431 cells is suggested to be functionally involved in phospholipase C activation.

Original languageEnglish
Pages (from-to)208-211
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume173
Issue number1
DOIs
Publication statusPublished - 1990 Nov 30

Fingerprint

Type C Phospholipases
Epidermal Growth Factor
Protein-Tyrosine Kinases
Inositol Phosphates
Chemical activation
Cultured Cells
Adenosine Triphosphate
Cells
Membranes
erbstatin

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitor. / Imoto, Masaya; Shimura, Naomi; Hideaki, Ui; Umezawa, Kazuo.

In: Biochemical and Biophysical Research Communications, Vol. 173, No. 1, 30.11.1990, p. 208-211.

Research output: Contribution to journalArticle

@article{0be858d314fc4f7da48b4a71c5496b8a,
title = "Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitor",
abstract = "Erbstatin, a tyrosine kinase inhibitor, inhibited epidermal growth factor (EGF)-induced inositol phosphate production in cultured A431 cells. However, it did not inhibit ATP-induced inositol phosphate production. Cytosolic but not membrane-associated phospholipase C was iactivated by EGF, and erbstatin inhibited enhancement of the phospholipiase C activity in EGF-treated cells. Thus, tyrosine kinase of A431 cells is suggested to be functionally involved in phospholipase C activation.",
author = "Masaya Imoto and Naomi Shimura and Ui Hideaki and Kazuo Umezawa",
year = "1990",
month = "11",
day = "30",
doi = "10.1016/S0006-291X(05)81042-3",
language = "English",
volume = "173",
pages = "208--211",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitor

AU - Imoto, Masaya

AU - Shimura, Naomi

AU - Hideaki, Ui

AU - Umezawa, Kazuo

PY - 1990/11/30

Y1 - 1990/11/30

N2 - Erbstatin, a tyrosine kinase inhibitor, inhibited epidermal growth factor (EGF)-induced inositol phosphate production in cultured A431 cells. However, it did not inhibit ATP-induced inositol phosphate production. Cytosolic but not membrane-associated phospholipase C was iactivated by EGF, and erbstatin inhibited enhancement of the phospholipiase C activity in EGF-treated cells. Thus, tyrosine kinase of A431 cells is suggested to be functionally involved in phospholipase C activation.

AB - Erbstatin, a tyrosine kinase inhibitor, inhibited epidermal growth factor (EGF)-induced inositol phosphate production in cultured A431 cells. However, it did not inhibit ATP-induced inositol phosphate production. Cytosolic but not membrane-associated phospholipase C was iactivated by EGF, and erbstatin inhibited enhancement of the phospholipiase C activity in EGF-treated cells. Thus, tyrosine kinase of A431 cells is suggested to be functionally involved in phospholipase C activation.

UR - http://www.scopus.com/inward/record.url?scp=0025596958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025596958&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(05)81042-3

DO - 10.1016/S0006-291X(05)81042-3

M3 - Article

C2 - 2256916

AN - SCOPUS:0025596958

VL - 173

SP - 208

EP - 211

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -